Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investors Events
  • Pre market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
October 30, 2024 2:18 PM 2 min read

Crocs Analysts Slash Their Forecasts After Q3 Results

by Avi Kapoor Benzinga Staff Writer
Follow
CROX Logo
CROXCrocs Inc
$83.84-0.10%
Overview

Crocs, Inc. (NASDAQ:CROX) reported third-quarter financial results and lowered its revenue guidance related to the HEYDUDE Brand on Tuesday.

The company reported adjusted earnings per share of $3.60 (+11%), beating the street view of $3.10. Quarterly revenues of $1.062 billion (+2%) beat the analyst consensus of $1.05 billion.

Crocs Brand revenues increased 7.4% to $858 million, or 7.9% on a constant currency basis. HEYDUDE Brand revenues decreased 17.4% to $204 million.

"We have sharpened our strategy around HEYDUDE as we work to create higher brand relevance through our product and marketing initiatives," said Andrew Rees, Chief Executive Officer. "HEYDUDE's recent performance and the current operating environment are signaling it will take longer than we had initially planned for the brand to turn a corner."

For the fourth quarter, the company sees adjusted diluted earnings per share of $2.20 to $2.28 versus $2.72 estimate. Revenues are expected to remain flat or increase slightly year over year. The Crocs brand is projected to grow by about 2%, while the HEYDUDE brand is expected to decline by 4% to 6%.

FY24 revenue growth is expected to be around 3% (the lower end of the previous 3% to 5% guidance), with Crocs brand growth at approximately 8% (prior view: 7% to 9%) and HEYDUDE brand revenue down about 14.5% (worse than the previous expectation of a 10% – 8% decline).

Crocs shares fell 0.8% to trade at $110.69 on Wednesday.

These analysts made changes to their price targets on Crocs following earnings announcement.

Considering buying CROX stock? Here’s what analysts think:

Read More:

  • Top 3 Tech And Telecom Stocks Which Could Rescue Your Portfolio For October
Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.


Posted In:
NewsPrice TargetMarketsAnalyst RatingsTrading IdeasPT Changes
  • Baird analyst Jonathan Komp maintained Crocs with an Outperform and lowered the price target from $190 to $180.
  • UBS analyst Jay Sole maintained the stock with a Neutral and lowered the price target from $146 to $122.
  • Keybanc analyst Ashley Owens maintained Crocs with an Overweight and cut the price target from $155 to $150.
  • Raymond James analyst Rick Patel downgraded the rating for Crocs from Outperform to Market Perform.
CROX Logo
CROXCrocs Inc
$83.84-0.10%
Overview
Comments
Loading...